Medical Technology Solutions Companies in Europe

Think Biosolution is a leading provider of chronic disease prevention platforms specifically designed for assisted living and home health care agencies. Based in Dublin, Ireland, and with a growing presence in Rochester, New York, we empower healthcare providers to proactively manage and mitigate the risks associated with chronic conditions such as cardiac disease, hypertension, and diabetes. Our NurseAnn platform, an Alexa-enabled nursing assistant, streamlines patient data collection, vital sign monitoring, and medication reminders, improving patient outcomes and reducing administrative burden.

We are committed to supporting the long-term care sector with innovative technology that enhances patient care and operational efficiency. Our solutions integrate seamlessly with existing workflows, offering a scalable and adaptable approach to chronic disease management. We serve a growing market of healthcare organizations seeking to improve patient health and reduce associated costs.

ElectroPhysiology Frontiers is a Milan, Italy-based MedTech company dedicated to revolutionizing the treatment of Atrial Fibrillation (AFib). We’ve developed a groundbreaking, easy-to-use ‘single-shot’ catheter ablation system designed to deliver more durable and long-lasting ablations, significantly reducing the risk of AFib recurrence after pulmonary vein isolation (PVI).

Our innovative catheter design, utilizing both pulsed-field ablation (PFA) and radiofrequency (RFA) technologies, streamlines the ablation process, making it safer and more efficient for clinicians.

Built upon decades of expertise in cardiac electrophysiology, EPF’s leadership team – comprised of internationally recognized professionals – is committed to advancing patient care through cutting-edge technology. We are focused on improving outcomes and positively impacting patients, healthcare professionals, and healthcare systems globally.

ElectroPhysiology Frontiers is a privately held company with a growing presence in both Italy and the United States, currently operating with a team of 2-10 dedicated professionals.

Lenstec UK is a leading UK-based manufacturer and supplier of premium intraocular lenses (IOLs) for cataract and refractive surgery, with over 25 years of experience.

We specialize in providing high-quality IOLs to the NHS and private sector, serving a global network of over 60 countries. Lenstec UK’s success is built on a strong foundation of innovation, accuracy, and reliability, coupled with a commitment to exceptional customer service.

As a subsidiary of Lenstec’s global organization, we pride ourselves on a stable, family-run corporate structure, fostering consistent relationships with our customers and stakeholders. Our dedication to excellence ensures we remain a trusted partner in ophthalmic care.

Gentian Diagnostics is a global medical diagnostics company headquartered in Moss, Norway, specializing in the development and manufacture of high-quality in vitro diagnostic (IVD) reagents.

We provide innovative solutions for a wide range of clinical chemistry analysers, focusing on key biomarkers like Cystatin C, Calprotectin, and Canine CRP. Our products are designed to improve accuracy and deliver faster results, supporting both human and veterinary healthcare professionals.

Gentian Diagnostics serves the global market through OEM partners and key distributors, committed to enhancing diagnostic efficiency and driving better treatment decisions. We are dedicated to advancing medical diagnostics with reliable and impactful reagents.

MedAlliance Swiss Medical Technology is a privately-owned medical technology company headquartered in Nyon, Switzerland, specializing in the development and commercialization of innovative drug-eluting balloon (DEB) technologies for the treatment of coronary and peripheral artery disease.

Founded in 2008, MedAlliance has dedicated itself to pioneering solutions for patients suffering from life-threatening cardiovascular conditions. We leverage breakthrough proprietary technology, including our unique MicroReservoirs made from biodegradable polymer intermixed with the anti-restenotic drug sirolimus, to deliver sustained drug release and improve patient outcomes.

MedAlliance’s commitment to innovation is exemplified by its receipt of Breakthrough Device Designation Status from the US FDA for its SELUTION SLR coronary DEB, and subsequent CE Mark approvals for both coronary and peripheral indications. Our CAT technology further enhances these solutions, providing a secure and effective method for balloon delivery. We are a global company with operations spanning Europe, North America, and Asia, dedicated to advancing cardiovascular care.

Dermoaroma is an Italian company specializing in advanced cell therapies, headquartered in Rome, Italy, with offices in Dubai and Malta. We’re dedicated to restoring the function and structure of aging and problematic skin through innovative formulations. Our core technology, Secretomes, elevates cell performance, rearchitecting skin’s structure and boosting regeneration.

Dermoaroma’s mission is to bring the future of aesthetic medicine to today, offering safe and effective solutions for a variety of aesthetic needs. We champion innovation, challenging the status quo with vanguard technologies and a commitment to scientific brilliance.

For over 16 years, Dermoaroma has been a leader in regenerative aesthetics, holding 14 registered scientific patents and utilizing a multi-patented formulation – Purasomes – that works by elevating the human body’s natural healing response. We’re committed to ethical conduct and ensuring the well-being of our staff and supply chain, upholding the highest standards of modern slavery and human rights practices.

CellaVision is a leading provider of digital hematology microscopy solutions, headquartered in Lund, Sweden. We specialize in automating blood analysis workflows for laboratories of all sizes, serving both human and animal health sectors.

Our core offering includes advanced analyzers, instruments, reagents, and sophisticated software, all designed to streamline hematology testing and improve diagnostic accuracy.

CellaVision leverages cutting-edge image analysis and artificial intelligence technologies to deliver a comprehensive and reliable solution. We are committed to empowering laboratories with the tools they need to achieve optimal performance and patient care. Founded in 1994, CellaVision has grown to become a global leader, with offices across North America, Japan, China, and Canada, supporting a diverse range of clients worldwide.

WallabyPhenox is a leading innovator in interventional neuroradiology, based in Bochum, Germany. Since 2005, we’ve dedicated ourselves to developing breakthrough and clinically proven technologies for treating neurovascular diseases like ischemic and hemorrhagic stroke.

We provide a growing portfolio of innovative treatment options, including the pRESET mechanical thrombectomy system, the p64 and p48 MW Flow Diverters for aneurysm treatment, and the pCONUS Implant for bifurcation aneurysms.

Our commitment to patient safety is underscored by the HPC Technology (Hydrophilic Polymer Coating), which reduces implant thrombogenicity. Furthermore, we are the exclusive distributor of the Avenir Coiling System developed by Wallaby Medical. WallabyPhenox is now part of the Wallaby Medical group, furthering our mission to improve patient outcomes through advanced neurovascular intervention.

InfraTec GmbH is a leading German provider of infrared sensor technology and thermal imaging solutions, based in Dresden. We specialize in the development and manufacture of high-performance infrared cameras and custom thermographic systems for a wide range of industries.

For over 35 years, InfraTec has been at the forefront of innovation in infrared technology, delivering cutting-edge solutions to meet the evolving needs of our clients. Our expertise spans from pyroelectric infrared detectors to complete thermographic automation systems, serving diverse applications including industrial process monitoring, non-destructive testing, and fire detection.

InfraTec’s commitment to quality and precision ensures reliable and accurate thermal imaging, empowering our customers to optimize their operations and enhance safety. We are a privately held company with over 240 employees, dedicated to pushing the boundaries of infrared sensing and measurement.

"TracInnovations makes it possible to scan and diagnose patients who move during a neurology MRI scan. Our passion is to make it possible to avoid sedation during pediatric MRI scans, increase patient comfort and improve the workflow."

Acurable is a fast-growing, venture backed MedTech start-up with offices in London and Seville. We create accurate and user-friendly wearable medical devices intended to be used by patients at home. Our award-winning, patented technology enables for the first time the automated diagnosis and management of respiratory conditions. It is the product of more than 10 years’ research at Imperial College London by Acurable’s founder, Professor Esther Rodriguez Villegas, and has been recognised as a breakthrough in respiratory medicine, winning some of the most respected awards in the industry, among them an XPrize and several Innovate UK grants. It has also featured in national and international media, including earlier this year in the BBC Horizon documentary How to Sleep Well with Michael Mosley. In 2020 our first product, AcuPebble SA100, became the first medical device in the world to obtain the CE mark for the automated diagnosis of obstructive sleep apnoea at home, and a few months later the product gained FDA clearance for home sleep apnoea testing in the US. AcuPebble SA100 is now in use within healthcare organisations across the UK and Europe, and will be launching in the USA in the coming months. At the same time we continue our research to develop new products that will fundamentally improve the lives of millions of people suffering from serious chronic conditions such as COPD, Asthma and Epilepsy.

At ABLE Human Motion we envision a world where everybody has the possibility to move freely. We are a Barcelona-based start-up developing robotic exoskeletons to improve the quality of life of people with disabilities.

MedTech company specialising in the development of precision medicine solutions for chronic inflammatory conditions. We develop prognostic and predictive biomarkers to detect disease at the early stage and to help personalise treatments.

Дијагностичка лабораторија со биохемиска и микробиолошка лабораторија, дел од Групацијата СИНЛАБ, Европски број 1 провајдер на лабораториски услуги. Основана: 2000 година како Приватна здравствена организација Адриалаб - Ординација по општа медицина и биохемиска лабораторија. Цели на компанијата: давање на лабораториски услуги од областа на хуманата медицина. Број на вработени: 60+, од кои 6 лекари специјалисти по медицинска биохемија и микробиологија со паразитологија Структура на вработените: повеќе од 60% со високо образование. Број на локации во Македонија: четири во Скопје (во К. Вода, Центар, Аеродром и Карпош), по една во Битола и Тетово. Акредитација: СИНЛАБ е акредитирана од ИАРМ (Институт за акредитација на Р. Македонија) согласно МКС ИСО 15189:2013 под реден број МЛ-001. СИНЛАБ е сертифицирана преку надворешна контрола на квалитет од INSTAND e.V., Германија и BIO-RAD, САД. Структура на клиенти: физички лица, лекарски ординации, поликлиники, болници, медицински и истражувачки лаборатории, работни организации. Седиште на компанијата: Огњен Прица (Антон Попов) бр.1, лок. 3,4,5, Скопје Управител: М-р д-р Маја Тодоровска, специјалист по медицинска биохемија

Satisform | DPA Med is a French medical equipment manufacturer based in Le Mans, specializing in advanced neuro-musculoskeletal rehabilitation technologies.

For over 20 years, Satisform has pioneered rhythmic lumbopelvic mobilization technologies, inspired by human movement science, to support functional recovery and mobility. Our flagship technologies, DPA Med® and DPA Sport®, deliver repetitive, controlled neuromotor stimulation in reduced mechanical constraint environments.

Satisform combines biomechanics, physiotherapy, and rehabilitation technology to help clinicians and movement professionals optimize mobility, functional capacity, and motor organization. We serve hospitals, clinics, physiotherapy centers, and sports medicine environments, supporting neurological, orthopedic, spinal, and gait-related rehabilitation. Today, Satisform technologies have been used by more than one million people worldwide.

confinis is a Switzerland-based regulatory consultancy specializing in medical device compliance, offering expert guidance to manufacturers navigating the complexities of the European Union Medical Device Regulation (EU MDR) and In Vitro Diagnostic Regulation (IVDR).

We support companies throughout the entire product lifecycle, from initial concept and design to market authorization and post-market surveillance. Our team of experienced regulatory professionals provides comprehensive services including clinical evaluation, technical documentation, quality management system (QMS) implementation, and post-market surveillance support.

confinis assists clients in achieving compliance with regulations such as 21 CFR Part 820, 21 CFR Part 4, ISO 13485, MDSAP, and the new EU AI Act. We are committed to helping our clients successfully launch and maintain their medical devices and IVDs in the European market, ensuring patient safety and regulatory adherence. We also offer Swiss Representative (CH REP) and UK Responsible Person (UK RP) services.

We have supported the registration of over 2,000 medical devices and 200 combination products, demonstrating our deep expertise and track record of success.

MEDICAL-X is a leading provider of high-fidelity simulation solutions, based in Arnhem, Netherlands.

We specialize in the design, development, and manufacture of a comprehensive range of simulation products, including realistic patient simulators, procedural task trainers, and specialized equipment for defense and emergency response training.

MEDICAL-X collaborates closely with medical experts to deliver cutting-edge technology that enhances hands-on, simulation-based education. Our solutions are trusted by universities, hospitals, and organizations worldwide, ultimately improving training outcomes and contributing to safer healthcare practices.

By improving training outcomes, we help reduce errors and save lives – one simulation at a time.

Galvani Bioelectronics is a pioneering medical research company based in Stevenage, Hertfordshire, UK, dedicated to developing bioelectronic medicines. We’re transforming lives through precision neuromodulation, combining GlaxoSmithKline’s life science expertise with Verily Life Sciences’ innovative software and electronics. Our focus is on implant-based therapies that directly modulate specific neural signals to organs central in chronic disease, offering safe, precise, and minimally invasive treatment options. We are currently enrolling patients in clinical studies for Rheumatoid Arthritis, Bladder Dysfunction, and other conditions, utilizing connected software to optimize therapy delivery. Galvani Bioelectronics represents a significant advancement in treating chronic diseases through targeted neuromodulation.

We specialize in immunomodulatory and non-immunomodulatory therapies, addressing a range of conditions including Rheumatoid Arthritis, Bladder Dysfunction, COPD, Multiple Sclerosis, Hypertension, SLE, Sleep Apnea, Psoriatic Arthritis, Type II Diabetes, Ankylosing Spondylitis, Crohn's Disease, Ulcerative Colitis, and Type 1 Diabetes.

Galvani’s approach leverages cutting-edge technology – small, efficient wireless electronics and keyhole surgery – to deliver these therapies with minimal invasiveness. Our commitment to innovation and patient well-being drives our research and development efforts, aiming to improve the lives of individuals suffering from debilitating chronic illnesses.

Inion Oy is a Finnish medical device company specializing in the development and commercialization of innovative bioabsorbable and bioactive implants. Based in Tampere, Finland, we serve the orthopedic, craniomaxillofacial, dental, sports medicine, and spinal surgery markets with a comprehensive portfolio of products.

Inion’s core expertise lies in our proprietary Inion® family of biomaterials, enabling us to create medical implants tailored to specific surgical applications, offering optimal bioabsorption and clinically proven performance.

Since 1999, Inion has established a strong international presence, with offices in Finland and the USA, and a network of specialist distributors in key territories, including the United States. We are committed to ‘Leave No Trace’ – providing solutions that promote natural healing and minimize patient recovery time.

To date, over one million of our bioabsorbable implants have been utilized in more than 300,000 surgical operations worldwide, demonstrating our commitment to quality and innovation.

Swift UK is a Scottish-based medical equipment manufacturer specializing in innovative microwave therapy systems.

We develop and supply advanced solutions for Podiatrists and Dermatologists, offering a precise and efficient method for treating soft tissue conditions. Our flagship product, the Swift system, delivers rapid treatment times – often in seconds – significantly improving patient outcomes and streamlining clinical workflows.

Swift UK leverages Emblation’s global expertise to provide cutting-edge technology within the dermatology and podiatry sectors. We are dedicated to advancing the field of soft tissue therapy through continuous research and development, ensuring our clients have access to the most effective and user-friendly tools available.

Established in 2007, Swift UK has quickly become a trusted partner for healthcare professionals seeking to enhance their practice with advanced microwave therapy solutions.

Incipio Devices SA is a Swiss manufacturer of high-precision acetabular orthopedic instruments, based in St-Blaise.

We specialize in designing, developing, and producing a comprehensive range of instruments for hip replacement surgery, including reamers, trays, and impactors.

Incipio Devices SA focuses on providing surgeons with reliable and innovative tools, ensuring optimal patient outcomes. Our commitment to quality and precision, combined with our experienced team, makes us a trusted partner in the field of orthopedic surgery.

Founded in 2015, we’ve grown to serve both domestic and international markets, including a presence in the United States. We are dedicated to continuous improvement and meeting the evolving needs of the medical community.

joimax is a Karlsruhe, Germany-based developer and marketer of complete systems for endoscopic minimally invasive spinal surgery. For over 25 years, joimax® has been a pioneer in this field, providing surgeons with innovative technologies like TESSYS®, iLESSYS®, and MultiZYTE® to perform procedures through small incisions and natural openings. Our commitment to comprehensive training and education empowers spine professionals worldwide to deliver the highest quality in endoscopic spine surgery. We prioritize patient well-being and outcomes through our cutting-edge solutions.

joimax® specializes in a range of endoscopic approaches, including transforaminal, interlaminar, and cervical techniques. Our systems, such as the Intracs® em navigation system and the Shrill® Spinner Blades, are designed to offer precision and efficiency during procedures for herniated discs, stenosis, pain therapy, and spinal stabilization.

As a global leader, joimax® operates internationally with locations in the US, Asia, and Singapore, demonstrating our dedication to serving a diverse patient population. We continue to invest in research and development to advance minimally invasive spine care and provide surgeons with the tools they need to succeed.

W.O.M. WORLD OF MEDICINE GmbH is a leading German manufacturer of minimally invasive surgical devices, based in Berlin.

For over 40 years, WOM has been a global specialist in uterine and abdominal laparoscopic procedures, renowned for its innovative pump and insufflator technologies. We provide essential tools for surgeons, enabling precision and reliability in endoscopic operations.

WOM distinguishes itself through a commitment to quality, extensive training programs for employees, and a supportive work environment. We are dedicated to advancing surgical care and fostering innovation within the medical technology industry.

Our global presence extends across Europe, Asia, and North America, with manufacturing facilities in Berlin, Ludwigsstadt, Reichenbach, and Hong Kong, serving a diverse range of healthcare providers.

PocketECG is a Polish medical technology company specializing in AI-driven cardiac monitoring solutions, headquartered in Warsaw. We provide innovative devices and platforms for long-term Holter, Cardiac Event, and Mobile Cardiac Telemetry analysis, enabling faster and more efficient arrhythmia diagnosis. Our flagship products, PocketECG and Kardiobeat.ai, combine portability with advanced AI algorithms to deliver unparalleled clinical precision and full disclosure data. We empower healthcare professionals with real-time insights, facilitating improved patient care and outcomes. Founded in 2009, PocketECG has grown to serve hundreds of healthcare institutions globally, including those in the United States, European Union, Asia, and the Middle East.

PocketECG’s core offering is the PocketECG device, a smartphone-sized, AI-driven ECG monitoring system that transmits real-time data directly to a secure cloud platform. This eliminates the need for patients to return to the clinic for follow-up visits, streamlining the diagnostic process.

Furthermore, our DeepRhythmAI (DRAI) platform utilizes FDA-cleared AI algorithms to quickly detect and classify arrhythmias across various third-party software and devices. We also offer the DeepRhythm Platform (DRP) for accurate arrhythmia detection, analysis, and reporting, alongside Virtual Cardiac Stress Test (VCAST) for advanced cardiac diagnostics.

PocketECG is committed to advancing cardiovascular care through continuous research and development, focusing on AI, next-generation diagnostic solutions, and clinical trials.

ICT International is a leading provider of protective coatings and technology solutions, based in Leek, UK, supporting businesses and industries in navigating the challenges of the ‘new normal’ post-COVID. With over 30 years of experience in managing epidemics at governmental and non-governmental levels, we offer a comprehensive package of solutions to sectors including aviation, cruise, entertainment, and hospitality. Our expertise in COVID Response and advice ensures our clients are well-equipped to mitigate risks and maintain operational resilience.

We specialize in delivering innovative coatings designed to combat infectious diseases and safeguard critical infrastructure.

ICT International leverages its global experience to provide tailored solutions, assisting organizations in adapting to evolving health and safety protocols.

From our headquarters in Leek, we also operate strategically in Orlando and Las Vegas, serving a diverse international clientele.

"The Flow depression app will help you understand, treat and prevent depression The Flow app is solely based on psychological research and neuroscience. The app uses a method called behaviour therapy to help you engage in antidepressant activities that significantly reduce symptoms of depression. Your virtual therapist guides you through more than 50 therapy sessions and gives you step-by-step instructions on how to improve sleep, diet, exercise and meditation."

A vaping awareness campaign providing evidence-based information and supportive articles for children and adults wishing to quit vaping, along with supportive resources for parents and schools. Did you know that there 230,000 11-17 year olds in the UK vape more than once a week? Or that there are 500,000 daily users of e-cigarettes in the UK in 2024 and rising, who have never-smoked? VapeFree works towards achieving primary prevention in raising awareness to prevent uptake by never-smokers, and secondary support for those motivated to, yet struggling to quit the third most addictive drug after heroin and cocaine. The campaign is primarily designed for never-smoker vapers and children and young adults, with a secondary demographic of ex-smoker vapers who, after 12 months of use or more (as advised by The National Centre for Smoking Cessation and Training) who are motivated to quit. We do not deny the efficacy of e-cigarettes in smoking cessation and tobacco harm reduction, and support their use for this purpose, but do not believe they should be a lifelong solution given the unknown long-term health risks of vaping, known health risks of nicotine addiction, and safer alternatives: fresh air. We will be able to provide health coaching to support those wishing to quit, alongside recruiting therapists to bolster formal support, and be giving in-person presentations to secondary schools in Jersey to target the epidemic amongst children and adolescents (although this is a UK wide campaign). We are also in advanced talks of developing a mobile phone app with the aim of utilising digital health technology to increase the cessation rates given the role digital technology plays in our culture today, especially amongst our future: the youth of today. Please Follow our Page and support the campaign, whether it's from engagement, signing up as a therapist, or donating to our soon-to-launch crowdfunding campaign your input is invaluable!

NeoPredics AG is a medical technology software company based in Regensburg, Germany, specializing in intelligent digital health solutions for maternal and neonatal care. We transform complex clinical data into predictive insights, empowering clinicians to make proactive decisions and improve patient outcomes. Our core service is the development and delivery of cutting-edge predictive analytics, particularly through BiliPredics, an advanced bilirubin prediction software, and PreFree, a prediction model for preeclampsia.

NeoPredics leverages a team of experienced industry executives, medical professionals, and data scientists to deliver personalized solutions that enhance care quality, reduce healthcare costs, and ultimately, save lives. We are dedicated to advancing clinical decision-making for women and children worldwide, establishing a new standard for precision medicine in this critical area of healthcare.

"We are driven by the mission to improve the lives of people with cancer by transforming the efficacy of cancer surgery. Our imaging, sensing and AI tools help surgeons to quickly and accurately detect cancer in real-time in the operating room, aiming to enhance surgical precision, improve patient outcomes, and reduce costs for healthcare systems."

"PIXIUM VISION harnesses rapid advances in visual processing, micro-electronics, opto-electronics, neurobiology, and intelligent software algorithms to develop Bionic Vision Systems utilizing its competencies in machine brain interface and artificial intelligence. These Bionic Vision Systems are aimed at compensating for profound vision loss and improving the independence, mobility and quality of life for patients suffering with retinal degenerative diseases."

We put better health in your hands with tools you can trust, advice you can action, and the support to get you there.

Buy 50mg oxymetholone from medipharm.uk. This tablet is used to treat certain types of anemia that present concentration 50 mg/tab and 50 tabs on per tablet packet. Learn the side effect, uses and order from our website.

Purekeys bietet medizinische Tastaturen und desinfizierbare Computermäuse für Medizin, Forschung und Industrie. Die Produkte kombinieren völlig glatte Oberflächen mit taktilem Schreibgefühl und ermöglichen schnelle Desinfektion in unter 10 Sekunden. Sie sind beständig gegen alle medizinisch üblichen Desinfektionsmittel und helfen bei der Vermeidung von Ansteckungsgefahren in Arztpraxen, Zahnarztpraxen, Krankenhäusern und der Lebensmittelindustrie.